Page not found

ICON Biotech will be onsite at #OCTNewEngland2026, 27– 28 October. Drop by booth \#69 to meet the ICON team and discuss how we support biotech organisations across clinical development, from early strategy through execut...

Regulatory requirements continue to evolve across global markets. Keeping pace with changes from the FDA, EMA, MHRA, PMDA, NMPA and other health authorities is critical for successful product development and lifecycle ma...

Sponsors adopting RBQM are moving beyond traditional monitoring models to more targeted, risk-based oversight approaches. In BioPharm International, Helen Yeardley discusses how technology, data-driven monitoring and ev...

ICON will be exhibiting at ACoP 2026 at the Gaylord National Resort & Convention Center in Maryland. Visit us at Booth \#19 to meet our experts, explore live demonstrations, and discuss your most challenging clinical pha...

Adverse effects of immunotherapies that are expected in oncology settings are not tolerated in autoimmune and other chronic diseases. Read our whitepaper to learn about key safety and toxicity needs for immunotherapies i...

Meet ICON at #ESMO26, booth \#8005, to discuss how our scientific insight, oncology expertise, connected site network and purpose-built technology can support your program from strategy to study delivery. Explore practic...

60 colleagues. One shared cause. On 27 September, 60 members of our ICON team in Argentina joined more than 12,500 people in Buenos Aires for the 20th Caminata Avon. Together, they completed the 4.5 km walk in support ...

Single-stop research publication decisioning. PubsHub Journals & Congresses provides everything you need to decide the best place to publish your work. 50+ metadata consideration points including deadlines and lead times...

Meet Brittany Savoca at the #GSSS, during the TA Round Table: Neurology & Alzheimer’s on October 16 at 4:45 pm, where she will share lessons learned from successful studies and share insights on fostering collaboration t...

The countdown to #OCTNordics is on, and ICON is proud to be sponsoring this year's event in Copenhagen on 20–21 October. Drop by booth \#41 to connect with our experts and explore how ICON is driving innovation and oper...

How can sponsors generate meaningful clinical insights earlier in neurodegenerative disease development? Join ICON specialists Paula Kopschina Feltes and Matthias Mohse as they explore innovative first-in-human study des...

A promising biomarker strategy can quickly become a development bottleneck if global implementation isn't planned from the outset. At WorldCDx on 8 October, ICON will discuss how sponsors can avoid common challenges rela...